Subgroup differences in public attitudes, preferences and self-reported behaviour related to deceased organ donation before and after the introduction of the ‘soft’ opt-out consent system in England: mixed-methods study

Subgroup differences in public attitudes, preferences and self-reported behaviour related to deceased organ donation before and after the introduction of the ‘soft’ opt-out consent system in England: mixed-methods study
Research
Paul Boadu, Leah McLaughlin, Jane Noyes, Stephen O’Neill, Mustafa Al-Haboubi, Lorraine Williams, Jennifer Bostock, Nicholas Mays
BMC Health Services Research, 21 November 2024
Open access
Abstract
Background
In the UK, over 7,000 people are on the waiting list for an organ transplant and there are inequalities in need, access and waiting time for organs, with notable differences between minority ethnic groups. In May 2020, England changed the law and introduced a ‘soft’ opt-out system of consent to organ donation with a view to increase consent rates. We aimed to learn more about the impact of the law change on attitudes and views likely to be relevant to consent to deceased organ donation between different population subgroups.
Methods
Mixed-methods design involving latent class analysis of data from twelve repeated cross-sectional surveys undertaken from 2015 to 2021 (n = 19,011); analysis of the law change survey dataset collected quarterly from 2018 to 2022 (n = 45,439); and interviews with purposively selected members of the public (n = 30) with a focus on minority perspectives.
Results
Support for the principle of deceased organ donation remained high and stable in the general population (80%) but was 20% lower among ethnic minorities. From 2018 to 2022, an average of 58% of the general population was aware of the law change; this was lower among minority ethnic groups (31%). We identified four population subgroups (supportive donors (24% of the population); unengaged donors (22%); uncommitted donors (46%); and unsupportive donors (9%)). Interview themes included the challenges of discussing organ donation decisions, balancing autonomy with respecting family relationships, targeted misinformation, frustrations at the lack of consensus between community leaders, limited understanding of what happens during the end-of-life care leading to organ donation, and how this aligns with cultural values and preferences.
Conclusion
Implementation of the law change has not been associated to date with any change in public attitudes and preferences likely to influence consent overall or in minority ethnic groups in England. Uncommitted donors may benefit from encouragement to express their organ donation decision, and unengaged donors from attempts to address mis/information, confusion, and uncertainty. Interventions to raise the consent rate need to take account of the significant role of the family as well as wider community influences on attitudes, preferences and decision-making, particularly among certain minority (ethnic) groups.

A review of consent policies in Dermatological Surgery in the United Kingdom and the impact of leaner pathways and teledermatology on consent

A review of consent policies in Dermatological Surgery in the United Kingdom and the impact of leaner pathways and teledermatology on consent
Aparna Potluru, Daniel Sokol, Aaron Wernham
Clinical and Experimental Dermatology, 21 November 2024
Abstract
   Obtaining valid consent is an ethical and legal requirement in clinical practice, ensuring patients are adequately informed about their treatments. Recent updates in consent policies, including GMC guidance, the Patterson inquiry report, and key legal rulings like Montgomery, emphasise a shift towards patient-centred care and the importance of a comprehensive patient-clinician dialogue. Budget constraints and increasing NHS demand have led to the adoption of digital solutions and streamlined pathways, such as teledermatology and direct booking to surgery, potentially compromising the consent process.

This review examines the current state of informed consent in UK dermatology, particularly in light of the Montgomery ruling, which requires clinicians to ensure patients are aware of all material risks and alternatives associated with their treatments. The two-stage consent process, involving consent at two distinct points, is advocated to allow patients adequate time for reflection and decision-making. However, challenges remain in pathways like one-stop clinics and direct booking for surgery, where limited face-to-face interaction and time constraints can undermine the quality of informed consent.

To mitigate these issues, integrating multimedia tools and standardised procedure-specific consent forms can enhance patient comprehension and satisfaction. These tools ensure consistent and clear communication of risks, benefits, and alternatives, maintaining robust informed consent amidst evolving healthcare delivery models. Sustaining a thorough and individualised dialogue throughout the patient care journey is essential for upholding patient autonomy and shared decision-making in dermatological surgery.

Unproven stem cell therapies: an evaluation of patients’ capacity to give informed consent

Unproven stem cell therapies: an evaluation of patients’ capacity to give informed consent
Research Article
Laura Langford, Patrick Foong
Griffith Law Review, 30 October 2024
Abstract
Capitalising on the hype surrounding regenerative medicine, there are clinics worldwide marketing unproven stem cell-based therapies to patients. Some patients have travelled overseas to access treatments they believe are safe and effective. This practice, known as stem cell tourism, could result in adverse effects in some patients. This paper seeks to examine how the industry could threaten the validity of the patient’s informed consent. The vulnerable groups include adults, minors and incompetent patients. Since patients are exposed to exaggerated claims and inaccurate information, this article argues that each cohort may not truly consent to such therapies. While each group hopes to obtain a miracle cure, the reality is that these purported medical treatments may not enable patients to give their informed consent, which thereby inhibits good decision-making. Accordingly, states could restrict patients’ access to unproven stem cell-based therapies to control the problem. This paper illustrates how the regulatory framework in countries such as Australia and the United States (U.S.) has allowed the industry to thrive. Recommendations on how states can take a restrictive stance against this complex phenomenon are proposed.

Exploring the Foundations of Informed Consent, Legal Capacity, Privacy, and Dignity in Medical Law and me

Exploring the Foundations of Informed Consent, Legal Capacity, Privacy, and Dignity in Medical Law and me
Parvina Ismayilova
Juridical Sciences and Education, July 2024; 75(75) pp 136-151
Abstract
This article presents a comparative study exploring the foundations of informed consent, legal capacity, privacy, and dignity in medical law across different jurisdictions. The concept of informed consent is fundamental to medical practice and is rooted in the principle of patient autonomy. Legal capacity, on the other hand, refers to an individual’s ability to make decisions about their own healthcare and is often closely linked to informed consent. Privacy and dignity are also crucial aspects of medical law, protecting the rights and autonomy of patients. Through a comparative analysis of laws and regulations in various countries, this study examines the legal frameworks surrounding informed consent, legal capacity, privacy, and dignity in medical practice. The research aims to identify common principles and differences in the implementation of these concepts, addressing potential challenges and areas for improvement. By shedding light on the foundations of informed consent, legal capacity, privacy, and dignity in medical law, this study contributes to a better understanding of the rights and responsibilities of patients and healthcare professionals. The findings may inform future developments in medical law and practice, promoting ethical and respectful treatment of patients and upholding their rights to autonomy and dignity.

Editor’s note: This is an Azerbaijani language publication.

Ethical Concerns Regarding the Timing of Written Consent

Ethical Concerns Regarding the Timing of Written Consent
Sean C. Wightman, Victoria Yin, Jacob S. Hershenhouse, Tsehay B. Abebe, Li Ding, Scott M. Atay, Takashi Harano, Anthony W. Kim, John N. Pagteilan, Abhineet Uppal, Baddr A. Shakhsheer
The Journal of Clinical Ethics, Winter 2024; 35(4)
Abstract
Objective
Thorough informed consent requires decision-making capacity, adequate information, lack of coercion, and an appropriate environment. Consent obtained in the preoperative area is hurried, limiting the quality of informed consent and the opportunity for patient reflection, characteristics inconsistent with patient-centered practice. The incidence of obtaining consent immediately prior to surgery is unknown.
Methods
Consecutive patients undergoing surgery at a single center between 1 June 2021 and 14 June 2021 were identified. Time between consent signature and operating room arrival time was measured. Three surgeons reviewed cases and categorized them as major or not major operations.
Results
78.7 percent (199/253) of patients arriving to the preoperative area the day of surgery signed written consent that day. 99.6 percent (248/249) of anesthesia consents were signed the day of surgery. Spanish as a primary language corelated significantly with consent signing on the day of surgery (p = .04). Race and distance traveled for surgery were not significantly associated with consent signing in the preoperative area. 79.3 percent (157/198) had consent signed within 90 minutes of arrival to the operating room. Among major outpatient cases, 77.8 percent (182/234) had consent signing in the preoperative area.
Conclusions
This demonstrates routine consent signing in the hurried preoperative setting, suggesting a potential source for improved informed consent. Additionally, language-based consenting disparities, specifically in Spanish, offer opportunity for improvement. The majority of consents were signed the day of surgery, in the preoperative area, and within 90 minutes prior to operating room start time. This offers an opportunity for improved patient-centered care.

Informed consent in assisted reproductive technology: Implications for pediatric clinicians

Informed consent in assisted reproductive technology: Implications for pediatric clinicians
Mary E Graham, Shannon Blee, Rebecca D Pentz, Emily Roebuck, Alexander H Hoon Jr, Mara Black
Developmental Medicine & Child Neurology, 17 November 2024
Abstract
After conceiving through assisted reproductive technologies (ART), parents may present to their pediatrician with concerns related to their child’s neurodevelopment, including whether their child’s health may be related to their use of ART. Pediatricians may be unfamiliar with the ART process and what the families endured up to this point, resulting in difficulty counseling parents through these discussions. Before presentation to the pediatrician, parents have undergone extensive evaluation with reproductive endocrinologists. During counseling, the reproductive endocrinologist provides information on maternal and childhood risks associated with ART. However, in this rapidly evolving field, providing comprehensive, patient-centered, informed consent is increasingly complex and counseling patients properly can be challenging. When parents have gone through the proper informed consent process, and when the pediatrician has an understanding of what this process entails, care of the child can be optimized. In this review, we discuss the complexities of the prenatal informed consent process that parents navigate before presenting to pediatricians. We emphasize the importance of these discussions and highlight ethical principles, as well as emotional, medical, legal, and financial stressors that parents face during ART, with the belief that this understanding will improve the care that pediatricians subsequently provide.

Consent to advanced imaging in antenatal pulmonary embolism diagnostics: Prevalence, outcomes of nonconsent and opportunities to mitigate delayed diagnosis risk

Consent to advanced imaging in antenatal pulmonary embolism diagnostics: Prevalence, outcomes of nonconsent and opportunities to mitigate delayed diagnosis risk
David R Vinson, Madeline J Somers, Edward Qiao, Aidan R Campbell, Grace V Heringer, Cole J Florio, Lara Zekar, Cydney E Middleton, Sara T Woldemariam, Nachiketa Gupta, Luke S Poth, Mary E Reed, Nareg H Roubinian, Ali S Raja, Jeffrey D Sperling
Academic Emergency Medicine, 17 November 2024
Abstract
Background
Nonconsent to pulmonary vascular (or advanced) imaging for suspected pulmonary embolism (PE) in pregnancy can delay diagnosis and treatment, increasing risk of adverse outcomes. We sought to understand factors associated with consent and understand outcomes after nonconsent.
Methods
This retrospective cohort study was undertaken across 21 community hospitals from October 1, 2021, through March 31, 2023. We included gravid patients undergoing diagnostics for suspected PE who were recommended advanced imaging. The primary outcome was verbal consent to advanced imaging. Diagnostic settings were non-obstetric (99% emergency departments [EDs]) and obstetrics (labor and delivery and outpatient clinics). Using quasi-Poisson regression, we calculated adjusted relative risks (aRRs) of consenting with 95% confidence intervals (CIs). We also reported symptom resolution and delayed imaging at follow-up and 90-day PE outcomes.
Results
Imaging was recommended for 405 outpatients: median age was 30.5 years; 50% were in the third trimester. Evaluation was more common in non-obstetric (83%) than obstetric settings (17%). Overall, 314 (78%) agreed to imaging and 91 (22%) declined imaging. Consenting was more prevalent in obstetric settings compared with non-obstetric settings: 99% versus 73% (p < 0.001). When adjusted for demographic and clinical variables, including pretest probability, only obstetric setting was independently associated with consenting: aRR 1.26 (95% CI 1.09-1.44). Seventy-nine (87%) patients declining imaging had 30-day follow-up. Eight of 12 who reported persistent or worsening symptoms on follow-up were again recommended advanced imaging and consented. Imaging was negative. None who initially declined imaging were diagnosed with PE or died within 90 days.
Conclusions
One in five gravid patients suspected of PE declined advanced imaging, more commonly in non-obstetric (principally ED) settings than obstetric settings. Patients symptomatic on follow-up responded favorably to subsequent imaging recommendations without 90-day outcomes. Improving the communication and documentation of informed consent and securing close follow-up for non-consenters may mitigate risks of missed and delayed PE diagnosis.

Editor’s note: Academic Emergency Medicine is the official journal of the Society for Academic Emergency Medicine.

Clinical staff attitudes towards opt-out consent for blood-borne virus screening in emergency departments in England

Clinical staff attitudes towards opt-out consent for blood-borne virus screening in emergency departments in England
Esther G Blakey, Cassandra E L Fairhead, Alison J Rodger, Fiona M Burns, Lucie Ralph, David R Chadwick
HIV Medicine, 13 November 2024
Abstract
Objective
Opt-out screening for blood-borne viruses (BBVs) in emergency departments (EDs) has been established in areas with a high prevalence of HIV diagnoses in England. This multi-site study explored the attitudes of healthcare workers (HCWs) towards BBV screening in EDs post-implementation.
Design
This was a cross-sectional electronic survey of HCWs.
Methods
Between November 2023 and February 2024, HCWs across 33 EDs in England participating in opt-out BBV screening were invited to complete a survey about the feasibility and acceptability of screening, including the opt-out consent process. Factors independently associated with acceptability of opt-out screening were identified using multivariable logistic regression. Free-text responses were analysed thematically.
Results
Responses from 610 HCWs in 19 EDs were provided: 50.4% were nurses, 43.1% doctors, and 6.5% other healthcare professionals. Acceptability of the screening programme and opt-out consent was high (90.3% and 77.7%, respectively), with some variation between EDs. Acceptability of opt-out consent was greater among doctors than among other HCWs, and among HCWs who proactively discussed screening further with patients who opted out. However, 50.8% of HCWs felt that patients should be verbally reminded at blood draw, and 44.3% of HCWs wanted more training in discussing opt-out screening with patients. Free-text answers suggested changes to test-ordering systems, including simple integration of tick boxes to document whether patients opted out and to block repeated testing.
Conclusions
There was substantial support from ED HCWs for routine opt-out ED BBV screening, including opt-out consent. Key areas suggested for improvement included changes to test-ordering systems and additional training for HCWs. Frequent preference for verbal reminders at the point of blood draw suggests continued HIV testing exceptionalism.

Improving the Consent Process for Superficial Abscesses Through Pre-printed Consent Forms

Improving the Consent Process for Superficial Abscesses Through Pre-printed Consent Forms
Sima Patel, Ceri Gillett
Cureus, 11 November 2024; 16(11)
Abstract
Introduction
Informed consent is essential to ensure that patients are appropriately educated about proposed procedures, including associated risks and potential benefits, to make a valid decision. Incision and drainage of an abscess is a common procedure performed by various healthcare professionals. Inconsistent practices in the consent process can lead to misunderstandings among the patient and have financial and legal complications for both the clinician and the hospital. This study aims to improve the consent process for the incision and drainage of a superficial abscess via the implementation of pre-printed consent forms.
Method
We conducted a retrospective, single-centre study to evaluate existing consent forms, found in patients’ notes, for the incision and drainage of superficial abscesses. The goal was to assess these forms for standardisation, ultimately developing a pre-printed consent form suitable for use by a diverse range of healthcare professionals.
Results
This study revealed significant inconsistencies in consent documentation. While 20 out of 22 (91%) consent forms included infection as a documented risk, only 11 out of 22 (50%) mentioned COVID-19 as a potential risk. The study found that 22 of our 22 (100%) consent forms were documented in black ink. Providing patients with copies of the consent forms can enhance their understanding by allowing them to review the information at home. Eight out of 22 (36%) patients were offered a copy, and 13 out of 22 consent forms (59%) were noted to have abbreviations, both of which may limit understanding and comprehension of the procedure. After implementing a pre-printed consent form, 14 clinicians surveyed (100%) reported that the forms were effective, with 12 out of 14 (86%) indicating they would use these pre-printed forms in their future practice.
Conclusion
The identified variations and inconsistencies in the consent process prompted the creation of a standardised pre-printed consent form. Feedback on this form has been positive, indicating its potential to transform the consent process. The sample size was small, so early results are positive; however, further ongoing work would be required to draw a more definitive conclusion.

Interventions and strategies for enhancing the consent process in neurosurgery. A systematic review of the literature

Interventions and strategies for enhancing the consent process in neurosurgery. A systematic review of the literature
Review Article
Ashraf Elmahdi, David Smith
British Journal of Neurosurgery, 3 November 2024
Abstract
Background
The informed consent process in neurosurgery aims to support patient autonomy and provide comprehensive information for decision-making. However, gaps in communication and understanding between patients and surgeons persist, that need to be addressed. This systematic review examined the interventions and strategies which to enhance the process of consent in neurosurgery.
Methods
A comprehensive search of databases and relevant sources to identify relevant studies for inclusion. Systematic review of prospective and retrospective studies that assess the effect of interventions which improve the consent process. Data collection and analysis involved independent reviewers assessing eligibility, study quality, and risk of bias. Findings from the included studies were used to write the review.
Main results
The reviewed identified seven studies notably revealed an educational and interactive consent process involving strategies like booklets, videos, multiple interviews, and interactive websites showed improvements in patient knowledge. Recall of risks decreased over time, and factors like age, education, and timing of consent influenced recall.
Authors’ conclusions
To maximise informed consent, neurosurgeons should consider various strategies. Tailoring communication-based on patient’s health literacy and treatment knowledge, involving their support system, and using a bullet-point consent form is essential. Utilising multiple modalities like verbal, static, and dynamic visuals improve information retention. Creative and memorable visual aids enhance comprehension. Allowing time for questions and team approach is superior.